- Home
- CCRN vs VERV Comparison
CCRN vs VERV Comparison
Compare CCRN & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- VERV
- Stock Information
- Founded
- CCRN 1986
- VERV 2018
- Country
- CCRN United States
- VERV United States
- Employees
- CCRN N/A
- VERV N/A
- Industry
- CCRN Professional Services
- VERV Medicinal Chemicals and Botanical Products
- Sector
- CCRN Consumer Discretionary
- VERV Health Care
- Exchange
- CCRN Nasdaq
- VERV Nasdaq
- Market Cap
- CCRN 447.2M
- VERV 384.2M
- IPO Year
- CCRN N/A
- VERV 2021
- Fundamental
- Price
- CCRN $13.23
- VERV $4.82
- Analyst Decision
- CCRN Hold
- VERV Strong Buy
- Analyst Count
- CCRN 5
- VERV 6
- Target Price
- CCRN $17.93
- VERV $25.75
- AVG Volume (30 Days)
- CCRN 248.8K
- VERV 2.9M
- Earning Date
- CCRN 05-07-2025
- VERV 05-14-2025
- Dividend Yield
- CCRN N/A
- VERV N/A
- EPS Growth
- CCRN N/A
- VERV N/A
- EPS
- CCRN N/A
- VERV N/A
- Revenue
- CCRN $1,258,238,000.00
- VERV $59,613,000.00
- Revenue This Year
- CCRN N/A
- VERV $6.18
- Revenue Next Year
- CCRN $5.37
- VERV N/A
- P/E Ratio
- CCRN N/A
- VERV N/A
- Revenue Growth
- CCRN N/A
- VERV 271.44
- 52 Week Low
- CCRN $9.58
- VERV $2.87
- 52 Week High
- CCRN $18.50
- VERV $9.31
- Technical
- Relative Strength Index (RSI)
- CCRN 22.64
- VERV 49.94
- Support Level
- CCRN $13.81
- VERV $3.89
- Resistance Level
- CCRN $13.96
- VERV $4.63
- Average True Range (ATR)
- CCRN 0.32
- VERV 0.42
- MACD
- CCRN -0.03
- VERV 0.03
- Stochastic Oscillator
- CCRN 1.18
- VERV 56.20
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.